BioVie Balance Sheet Health

Financial Health criteria checks 6/6

BioVie has a total shareholder equity of $14.1M and total debt of $3.3M, which brings its debt-to-equity ratio to 23.6%. Its total assets and total liabilities are $21.2M and $7.2M respectively.

Key information

23.6%

Debt to equity ratio

US$3.32m

Debt

Interest coverage ration/a
CashUS$20.02m
EquityUS$14.07m
Total liabilitiesUS$7.17m
Total assetsUS$21.24m

Recent financial health updates

Recent updates

BioVie: Recent Data In Alzheimer's Suggests +100% Upside Potential Within A Year

Oct 14

BioVie: Possibly Setting Up For Success With Alzheimer's And Parkinson's Results Imminent

Sep 06

BioVie: Four Potential Catalysts Around The Corner

Jun 07

Financial Position Analysis

Short Term Liabilities: BIVI's short term assets ($20.2M) exceed its short term liabilities ($6.8M).

Long Term Liabilities: BIVI's short term assets ($20.2M) exceed its long term liabilities ($332.7K).


Debt to Equity History and Analysis

Debt Level: BIVI has more cash than its total debt.

Reducing Debt: BIVI had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BIVI has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: BIVI is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies